These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 36571985)

  • 1. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
    Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
    Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.
    Tada H; Takahashi H; Kawabata-Iwakawa R; Nagata Y; Uchida M; Shino M; Ida S; Mito I; Matsuyama T; Chikamatsu K
    Sci Rep; 2020 Dec; 10(1):21573. PubMed ID: 33299117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
    Payne K; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
    Head Neck; 2022 Nov; 44(11):2545-2554. PubMed ID: 35932094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT-related transcription factors and protein stabilization mechanisms involvement in cadherin switch of head and neck squamous cell carcinoma.
    Ingruber J; Dudás J; Savic D; Schweigl G; Steinbichler TB; Greier MDC; Santer M; Carollo S; Trajanoski Z; Riechelmann H
    Exp Cell Res; 2022 May; 414(1):113084. PubMed ID: 35219646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
    Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
    Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
    Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
    Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
    Wan Y; Liu H; Zhang M; Huang Z; Zhou H; Zhu Y; Tao Y; Xie N; Liu X; Hou J; Wang C
    Head Neck; 2020 May; 42(5):1067-1076. PubMed ID: 32048783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma.
    Tada H; Takahashi H; Ida S; Mito I; Matsuyama T; Chikamatsu K
    Anticancer Res; 2021 Feb; 41(2):885-893. PubMed ID: 33517294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma.
    Tada H; Takahashi H; Kuwabara-Yokobori Y; Shino M; Chikamatsu K
    Oral Oncol; 2020 Mar; 102():104558. PubMed ID: 32044652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
    Zhu D; He X; Li Y; Li G; Chen M
    Sci Prog; 2024; 107(1):368504241237888. PubMed ID: 38545800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.
    Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF
    Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
    Tada H; Takahashi H; Ida S; Nagata Y; Chikamatsu K
    Anticancer Res; 2020 Jun; 40(6):3559-3564. PubMed ID: 32487658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma.
    Chikamatsu K; Tada H; Takahashi H; Kuwabara-Yokobori Y; Ishii H; Ida S; Shino M
    Oral Oncol; 2019 Feb; 89():34-39. PubMed ID: 30732956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
    Shi E; Wu Z; Karaoglan BS; Schwenk-Zieger S; Kranz G; Abdul Razak N; Reichel CA; Canis M; Baumeister P; Zeidler R; Gires O
    J Biomed Sci; 2023 Aug; 30(1):72. PubMed ID: 37620936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
    Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
    PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences.
    Lee H; Park S; Yun JH; Seo C; Ahn JM; Cha HY; Shin YS; Park HR; Lee D; Roh J; Heo HJ; Baek SE; Kim EK; Lee HS; Kim CH; Kim YH; Jang JY
    J Med Virol; 2024 Jan; 96(1):e29386. PubMed ID: 38235919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.